JPWO2023163203A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023163203A5
JPWO2023163203A5 JP2024503306A JP2024503306A JPWO2023163203A5 JP WO2023163203 A5 JPWO2023163203 A5 JP WO2023163203A5 JP 2024503306 A JP2024503306 A JP 2024503306A JP 2024503306 A JP2024503306 A JP 2024503306A JP WO2023163203 A5 JPWO2023163203 A5 JP WO2023163203A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
disease
glomerular
symptom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024503306A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023163203A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/007230 external-priority patent/WO2023163203A1/ja
Publication of JPWO2023163203A1 publication Critical patent/JPWO2023163203A1/ja
Publication of JPWO2023163203A5 publication Critical patent/JPWO2023163203A5/ja
Pending legal-status Critical Current

Links

JP2024503306A 2022-02-28 2023-02-28 Pending JPWO2023163203A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022029773 2022-02-28
PCT/JP2023/007230 WO2023163203A1 (ja) 2022-02-28 2023-02-28 腎臓疾患の予防および／または治療用医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2023163203A1 JPWO2023163203A1 (https=) 2023-08-31
JPWO2023163203A5 true JPWO2023163203A5 (https=) 2025-12-05

Family

ID=87766272

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503306A Pending JPWO2023163203A1 (https=) 2022-02-28 2023-02-28

Country Status (4)

Country Link
US (1) US20250170116A1 (https=)
EP (1) EP4487848A4 (https=)
JP (1) JPWO2023163203A1 (https=)
WO (1) WO2023163203A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023276828A1 (ja) * 2021-06-29 2023-01-05 国立大学法人大阪大学 腎障害の予防および／または治療用医薬組成物、並びにオートファジー活性化剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006114706A1 (en) * 2005-04-26 2006-11-02 Pfizer Limited Triazole derivatives as vasopressin antagonists
WO2008054702A1 (en) * 2006-10-31 2008-05-08 Schering Corporation Anilinopiperazine derivatives and methods of use thereof
EP2356111A1 (en) * 2008-11-10 2011-08-17 Schering Corporation Compounds for the treatment of inflammatory disorders
US9006450B2 (en) * 2010-07-01 2015-04-14 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical compositions and uses thereof
ES2968678T3 (es) * 2018-04-27 2024-05-13 Univ Osaka Inhibidores del canal TRPC3 o TRPC6
WO2020102575A1 (en) * 2018-11-16 2020-05-22 Inception Ibd, Inc. Heterocyclic aminothiazoles and uses thereof
JP7594274B2 (ja) 2019-10-24 2024-12-04 国立大学法人大阪大学 難聴の予防および／または治療用医薬組成物
WO2023276828A1 (ja) * 2021-06-29 2023-01-05 国立大学法人大阪大学 腎障害の予防および／または治療用医薬組成物、並びにオートファジー活性化剤

Similar Documents

Publication Publication Date Title
JP2023002662A5 (https=)
JP2024071370A5 (https=)
JP2024516371A5 (https=)
JP2021063088A5 (https=)
JP2021504423A5 (https=)
JP2021098728A5 (https=)
JP2023098946A5 (https=)
JP2022068329A5 (https=)
JP2025013344A5 (https=)
JP2024540183A5 (https=)
JPWO2023195530A5 (https=)
JP2017528507A5 (https=)
FI3716979T3 (fi) 4-pyrimidiinisulfamidijohdannaisen ja SGLT-2-inhibiittorin yhdistelmä endoteliiniin liittyvien sairauksien hoitamiseksi
JP2006526031A5 (https=)
JP2017526716A5 (https=)
JP2019533660A5 (https=)
JP2011516417A5 (https=)
JP2015510916A5 (https=)
JP2023116697A5 (https=)
JP2021529829A5 (https=)
JP2008513510A5 (https=)
JP2024541569A5 (https=)
JP2013507442A5 (https=)
JP2017505809A5 (https=)
JP2019218379A5 (https=)